Back
ESC Premium Access

Impact of history of vascular disease on lipoprotein(a) associations with cardiovascular outcomes: a Mendelian randomisation study in 283,658 UK Biobank participants

Session: How good/bad are we in treating lipids
Topic: Epidemiology
Speaker: Doctor A. Stiby (Oxford, GB)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Alexander Stiby

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
0 follower

6 more presentations in this session

Intensification of lipid lowering therapy before and after publication of the IMPROVE-IT trial: A temporal analysis from the SPUM-ACS cohort

Speaker: Doctor B. Gencer (Lausanne, CH)

Access
Abstract
Slides
Like
Thumbnail

Attributable risk proportion of uncontrolled low-density lipoprotein cholesterol in recurrent acute coronary syndromes

Speaker: Doctor E. Martinez Rey-Ranal (Elche, ES)

Access
Abstract
Slides
Like
Thumbnail

Statin treatment in children with familial hypercholesterolemia in Scandinavia

Speaker: Doctor K. Svendsen (Oslo, NO)

Access
Abstract
Slides
Like
Thumbnail

Cost-effectiveness of evolocumab in patients with high atherosclerotic cardiovascular risk in Sweden

Speaker: Doctor E. Hagstrom (Uppsala, SE)

Access
Abstract
Slides
Like
Thumbnail

Very low achieved low-density lipoprotein cholesterol level with alirocumab treatment after acute coronary syndrome: ODYSSEY OUTCOMES

Speaker: Professor G. Schwartz (Aurora, US)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

How good/bad are we in treating lipids

Speakers: Doctor A. Stiby, Doctor B. Gencer, Doctor E. Martinez Rey-Ranal, Doctor K. Svendsen, Doctor E. Hagstrom...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources